Alexandria Real Estate Equities
ARE
#2319
Rank
ยฃ5.89 B
Marketcap
ยฃ34.11
Share price
-2.38%
Change (1 day)
-56.17%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -ยฃ10.57 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are ยฃ2.97 Billion. In 2024 the company made an earning of ยฃ0.52 Billion, an increase over its 2023 earnings that were of ยฃ0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ10.57 Million-102.02%
2024 ยฃ0.52 B96.11%
2023 ยฃ0.26 B-53.56%
2022 ยฃ0.57 B-3.96%
2021 ยฃ0.59 B-20.26%
2020 ยฃ0.74 B72.88%
2019 ยฃ0.43 B3.11%
2018 ยฃ0.42 B73.54%
2017 ยฃ0.24 B464.88%
2016 ยฃ42.87 M-77.32%
2015 ยฃ0.18 B36.31%
2014 ยฃ0.13 B-10.81%
2013 ยฃ0.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.88 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.41 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.87 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.74 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.18 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ97.74 M-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA